Lowenstein Sandler represented Celldex Therapeutics in the offering.Celldex Therapeutics, Inc. (Celldex) (Nasdaq: CLDX) executed its $287.5 million public offering of common stock. Jefferies, SVB Leerink, Guggenheim…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
